Your Top 100 most-cited badge

A badge for your website, a sentence for your CV, and a permanent page where anyone can check the rank.

The article

LBA1 A randomized multicenter open label phase III trial comparing enzalutamide vs a combination of Radium-223 (Ra223) and enzalutamide in asymptomatic or mildly symptomatic patients with bone metastatic castration-resistant prostate cancer (mCRPC): First results of EORTC-GUCG 1333/PEACE-3

Silke Gillessen, Ananya Choudhury, Fred Saad C, Enrique Gallardo, A. Soares, Yohann Loriot and 12 more

Rank
67 of 3,853
Percentile
top 1.8%
Where
Annals of Oncology, 2024
Citations
39

From the 2024 list, OpenAlex counts as of 2026-10-29.

Prefer not to be listed? The same link lets you withhold your name on every list; the article stays, your name does not. Questions: team@avidnote.com.